The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Celgene; Lilly; Novartis/Ipsen; Roche/Genentech
EVESOR, the first model-based multi-parameter academic phase 1 trial meant to optimize the benefit/toxicity ratio of everolimus (EVE) and sorafenib (SOR) combination: Initial results.
 
Benoit You
Consulting or Advisory Role - Menarini; Roche/Genentech; Teva
 
Mevidette El Madani
No Relationships to Disclose
 
Emilie Henin
No Relationships to Disclose
 
Michel Tod
No Relationships to Disclose
 
Denis Maillet
No Relationships to Disclose
 
Julien Peron
No Relationships to Disclose
 
Rodriguez-Lafrasse Calire
No Relationships to Disclose
 
Pierre-Jean Valette
No Relationships to Disclose
 
Thibaud Lefort
No Relationships to Disclose
 
Philippe Cassier
No Relationships to Disclose
 
Juliette Hommel-Fontaine
No Relationships to Disclose
 
Jerome Guitton
No Relationships to Disclose
 
Catherine Barrois
No Relationships to Disclose
 
Gilles Freyer
Consulting or Advisory Role - Amgen; Pierre Fabre; Roche/Genentech; Sanofi